Covered recipient · General Payments record
STEPHEN FITZGERALD
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018
$142.97
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $142.97 | 9 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $43.36 | 3 |
| Synergy Pharmaceuticals Inc | $31.86 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $23.53 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.46 | 1 |
| Braintree Laboratories, Inc. | $13.84 | 1 |
| Gilead Sciences, Inc. | $12.92 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $142.97 | 9 |
Payment records · PY2018 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie, Inc. | $19.09 | 07/30/2018 | Food and Beverage | Undisputed | 01/23/2026 | 571196915 | CMS |
| AbbVie, Inc. | $13.44 | 09/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | 571219343 | CMS |
| AbbVie, Inc. | $10.83 | 11/09/2018 | Food and Beverage | Undisputed | 01/23/2026 | 571335999 | CMS |
| Boston Scientific Corporation | $23.53 | 02/22/2018 | Food and Beverage | Undisputed | 01/23/2026 | 548846923 | CMS |
| Braintree Laboratories, Inc. | $13.84 | 10/29/2018 | Food and Beverage | Undisputed | 01/23/2026 | 535592023 | CMS |
| Gilead Sciences, Inc. | $12.92 | 07/11/2018 | Food and Beverage | Undisputed | 01/23/2026 | 592382295 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.46 | 07/30/2018 | Food and Beverage | Undisputed | 01/23/2026 | 589304457 | CMS |
| Synergy Pharmaceuticals Inc | $12.50 | 07/25/2018 | Food and Beverage | Undisputed | 01/23/2026 | 617245619 | CMS |
| Synergy Pharmaceuticals Inc | $19.36 | 12/06/2018 | Food and Beverage | Undisputed | 01/23/2026 | 617284169 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.